Navigation Links
TIGroup Names Dennis M. Smith as Chief Financial Officer
Date:9/26/2007

LOS ANGELES, Sept. 26 /PRNewswire-FirstCall/ -- TIGroup, Inc. (OTC Bulletin Board: TISG), a California-based financial solutions provider to the healthcare industry focused on ambulatory surgical centers (ASCs) and other businesses designed to deliver quality healthcare services outside of traditional hospital settings, today named Dennis M. Smith as the company's chief financial officer. He has served as a director on the company's board since 2001.

Smith was most recently chief executive officer of Cross Shore Acquisition Corporation, a special purpose acquisition company listed on the Alternative Investment Market of the London Stock Exchange. On August 29, 2007, Cross Shore completed the acquisition of Research Pharmaceutical Services, Inc. (RPS), a provider of integrated clinical development solutions to the bio- pharmaceutical industry. Smith continues to serve as a director of RPS.

Prior to Cross Shore, Smith co-founded and served as vice chairman and chief financial officer of Vsource, Inc., the predecessor to TIGroup. Through Vsource Asia, a subsidiary based in Malaysia, Vsource provides business process outsourcing solutions for Fortune 500 and Global 500 companies in the Asia-Pacific region. Following the sale of Vsource Asia in 2004, Smith served as chairman and chief executive officer of Vsource until July 2005. He continues to serve as a non-executive director, consultant and member of the board of Vsource Asia.

Smith lived and worked in Asia for 28 years. Prior to founding Vsource, he co-founded and served as general partner of ChinaVest, one of the earliest and largest independent private equity firms in Asia. In addition, he held senior positions in commercial and investment banking with First Chicago Corp. (now JPMorgan Chase) in Hong Kong, Singapore and the Philippines. He holds an MBA degree from Loyola University of Chicago.

TIGroup CEO David Hirschhorn said, "We are pleased to welcome Dennis to the company. His leadership and vision made him an excellent candidate. He will play a critical role in the growth of TIGroup as we introduce our re- capitalization services to the ASC market. We feel fortunate to have onboard an individual with Dennis' acquisition experience, fundraising abilities, financial expertise and public company credentials."

Smith said, "David has done a tremendous job in positioning TIGroup. As an early investor, I have been watching the company's progress from a distance for some time now and am excited about taking a more hands-on role. The opportunity to build a portfolio of investments in profitable, well-run ASCs delivering consistently healthy cash flows in the manner that TIGroup is pursuing is unique. The potential market is also quite significant in size and I look forward to working hard with David and the board to capitalize on it."

About TIGroup, Inc.

TIGroup is a financial solutions provider to the healthcare industry focused on ambulatory surgical centers (ASCs) and other businesses designed to deliver quality healthcare services outside of traditional hospital settings. The company is building a diversified portfolio of preferred minority interests in profitable ASCs and acquired majority stakes in select centers and is working to accelerate its re-capitalization offering to significantly scale its portfolio. For more information, visit http://www.tig3.com.

A profile for investors can be accessed at http://www.hawkassociates.com/tisgprofile.aspx. For investor relations information, contact Frank Hawkins or Julie Marshall, Hawk Associates, at (305) 451-1888, e-mail: info@hawkassociates.com. An online investor kit including press releases, current price quotes, stock charts and other valuable information for investors may be found at http://www.hawkassociates.com and http://www.americanmicrocaps.com. To receive free e-mail notification of future releases for TIGroup, sign up at http://www.hawkassociates.com/email.aspx.

About Hawk Associates Inc.

As a leading full service investor relations firm, Hawk Associates specializes in helping microcap and small cap companies break through the information clutter and attain the valuation they deserve by maximizing awareness and attracting investor attention. Hawk serves clients in the U.S., U.K., China and Vietnam. For more information about Hawk Associates, visit http://www.hawkassociates.com or contact Frank Hawkins or Julie Marshall at (305) 451-1888, e-mail: info@hawkassociates.com.

Safe-Harbor Statement: Under the Private Securities Litigation Reform Act of 1995. This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial condition or results of operations; (iii) the company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the company's Forms 10-K and 10-Q filed with the SEC.


'/>"/>
SOURCE TIGroup, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Vietnamese Scientists Unravel Genetic Code Of Bird Flu Virus
2. Financial Allowances Being Offered To Poor Vietnamese HIV Carriers
3. Gene Bias: Onomastics of Shared Surnames among Men Reveals Genetic links
4. AIDS Funding Grants Dependant on Tracking Patients Names Efficiently
5. Health Minister Wants Names of Uncooperative Hospital Consultants
6. Chinese PLA Names Bogus Army Medical Bodies Selling Fake Drugs
7. Over 50 Vietnamese Girls Faint Due to Mass Hysteria
8. All U.S. States To Begin Names-Based Reporting of HIV Cases by End of 2007
9. Rajasthan Directs Doctors to Prescribe Medicines by Generic Names
10. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
11. Iodex goes to SmithKline Beecham consumer Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... The threat of nuclear warfare has ... a company involved in the underground testing of nuclear weapons. Years later, when her ... Workers of the Cold War Nuclear Testing,” Clayton exposes the critical decisions made by ...
(Date:2/27/2017)... ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. – ... disclosed that despite scientific studies, the Center for Disease Control ( CDC ) and ... . Kenneth B. Liegner, M.D. has compiled into a single volume a compelling ...
(Date:2/27/2017)... ... 2017 , ... New Jersey ranks among the top five states in the ... need for advanced services is growing. , Project WE vs C is a ... with their non-profit partners in their fight against cancer and in support of their ...
(Date:2/26/2017)... ... February 26, 2017 , ... LatitudeC Baby Products, an ... announced it would be offering some it’s exclusive product line to the public ... and unique baby clothing/feeding products, will team up with AMAZON to distribute a ...
(Date:2/26/2017)... Florida (PRWEB) , ... February 26, 2017 , ... ... of Parkinson’s disease (PD) in persons with a specific LRRK2 mutation, according to ... Congress. , Previous studies have provided evidence of a link between pesticides and ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Feb. 23, 2017  Directors from Pharma To Market Pty Ltd ... joined forces, resulting in the founding of Pharma To Market Pte ... To Market are pleased to announce their expansion into ... Singapore . The company are delighted to appoint ... the Singapore based entity. Joelle brings with ...
(Date:2/24/2017)... 2017 Non-alcoholic steatohepataitis (NASH) Pipeline ... drugs being developed for the treatment of ... that are in various phases of development ... on novel pharmacologic drugs & regenerative medicines ... recombinant proteins and RNA-based therapeutics, but excludes ...
(Date:2/24/2017)... , Feb 24, 2017 ... Committee,s proposal for a new Board of Directors that ... The 2016-2017 Nomination Committee comprises representatives of the company,s ... quarter of 2016 who have accepted a seat on ... The composition of the 2016-2017 Nomination Committee was as ...
Breaking Medicine Technology: